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Abstract
Background: The “Th2 hypothesis for asthma” asserts that an increased ratio of Th2:Th1 cytokine production plays
an important pathogenic role in asthma. Although widely embraced, the hypothesis has been challenged by
various empirical observations and has been described as overly simplistic. We sought to establish whether CD3
+CD28-mediated and antigen-independent accumulation of type 1 and type 2 T cells differs significantly between
nonasthmatic and asthmatic populations.
Methods: An ex vivo system was used to characterize the regulation of IFN-g-producing (type 1) and IL-13-
producing (type 2) T cell accumulation in response to CD3+CD28 and IL-2 stimulation by flow cytometry.
Results: IL-13-producing T cells increased in greater numbers in response to antigen-independent stimulation in
peripheral blood lymphocytes from female atopic asthmatic subjects compared with male asthmatics and both
male and female atopic non-asthmatic subjects. IFN-g
+ T cells increased in greater numbers in response to either
antigen-independent or CD3+CD28-mediated stimulation in peripheral blood lymphocytes from atopic asthmatic
subjects compared to non-asthmatic subjects, regardless of gender.
Conclusions: We demonstrate that T cells from asthmatics are programmed for increased accumulation of both
type 2 and type 1 T cells. Gender had a profound effect on the regulation of type 2 T cells, thus providing a
mechanism for the higher frequency of adult asthma in females.
Background
Asthma is frequently labeled a “Th2-like” disorder,
based on an inflammatory profile in the asthmatic air-
way and is characterized by preferential elaboration of
Th2 T cells and their cytokines [1-3]. After allergen
challenge, elevated levels of the type 2 cytokines inter-
leukin (IL)-4 and IL-13 are found in the airways of
asthma subjects, associated with an influx of type 2 cells
and eosinophils [1-3]. The preponderance of IL-4 and
IL-13 relative to the type 1 cytokine IFN-g is believed to
promote feed-forward mechanisms of allergic inflamma-
tion in asthma. However, several observations suggest
that the “Th2 hypothesis” as applied to asthma is overly
simplistic. Although the ratio of type 2 cytokines to
interferon (IFN)-g is higher in asthmatics than in non-
asthmatic subjects, levels of both cytokines are often
dramatically increased in allergen-challenged asthmatics
[4,5]. Respiratory infections, known to induce IFN-g
levels, have been proposed to protect against asthma
development but also induce or worsen exacerbations in
subjects with established asthma [1,4,6-8]. A number of
studies also suggest that IFN-g is important in the survi-
val and activation of eosinophils [9,10].
Numerous factors regulate the accumulation of T cell
subsets. Trafficking of T cells to sites of inflammation
(e.g. to the airways in lungs), from peripheral blood and
lymphoid tissues is one important regulatory compo-
nent. Reduced numbers of regulatory T cells are
hypothesized to influence allergen-specific increases in
type 2 T cells in asthmatics [11]. The presence of regu-
latory stimuli and how T cell numbers increase in
response to both antigenic and non-antigenic stimuli
also determine absolute and relative numbers of type 1
and type 2 cells. Studies to date examining mixed T cell
populations in vitro have characterized the effects of
both antigenic, CD3-mediated and antigen-independent,
bystander (e.g., IL-2, IL-15) stimuli, as well as “polariz-
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exhibit distinct regulatory features is not known.
To address this question we compared the regulation
of T cell subtype accumulation in T cells obtained from
both atopic asthmatic and non-asthmatic subjects. Our
results reveal that under various conditions T cells from
asthmatics appear programmed for increased accumula-
tion of both type 2 and type 1 cells, and surprisingly,
gender plays a role in the regulation of type 2 cells.
Methods
Subject populations
Peripheral venous blood was obtained from nonasthmatic
(control) and atopic asthmatic human adults after
informed consent was provided, in accordance with a
Wake Forest University School of Medicine Institutional
Review Board-approved protocol and the Helsinki
Declaration. The criteria for being included in the atopic
asthmatic population are provided in Additional File 1.
All subjects refrained from taking asthma control medi-
cations at least 12 h prior to blood draw. Characteristics
of asthmatic subjects studied in this work are presented
in Table S1 in Additional File 1. Control subjects were
healthy adults who had not been diagnosed or treated for
asthma. All female control subjects, but <25% of male
controls, underwent clinical testing to: 1) rule out asthma
(history of symptoms, reversibility of FEV1 decrement,
airway hyperresponsiveness as assessed by methacholine
challenge, exclusion of other respiratory disorders); and
2) evaluate atopy by skin prick test to a panel of standard
common aeroallergens. For some subjects, certain out-
comes were not included in analyses because of missing
data resulting from insufficient cell numbers.
Cell culture
Peripheral blood lymphocytes (PBL), isolated by stan-
dard procedures [15] (>98% lymphocytes, as assessed by
flow cytometry), were cultured in RPMI-1640 media
supplemented with 5% pooled human plasma. Before
culture (day 0), after 5-d culture with 50 U/ml recombi-
nant human IL-2 + IL-12-neutralizing monoclonal anti-
body (aIL-12) + CD28 monoclonal antibody + CD3
monoclonal antibody (plate-bound), or after 6-d culture
with 50 U/ml IL-2 + IL-12-neutralizing monoclonal
antibody, cells were collected and assessed for viability
and cell numbers with an automated cell counter
(ViCell, BeckmanCoulter). Anti-IL-12 mAb was included
to exclude any influence of IL-12 potentially released
from the few contaminating monocytes (see Loza et al.
[16]). For “TH2-polarized” cultures, 50 U/ml IL-2, 5 ng/
ml IL-4 and IL-12-neutralizing monoclonal antibody
were included in the CD3+CD28-stimulated cultures
described above. For “TH1-polarized” cultures, 50 U/
ml IL-2, 2 ng/ml IL-12, and TNF-a-neutralizing
monoclonal antibody were included in the CD3+CD28-
stimulated cultures described above (but without IL-12-
neutralizing monoclonal antibody). See Additional File 1
for additional details about culture conditions.
Cytokine production
After culture and counting an aliquot of cells, 2-4 × 10
6
cells/250 μl were stimulated for cytokine production
(5-h with 2nM phorbol myristate acetate (PMA), 0.2 μg/
ml calcimycin, 100 U/ml IL-2, 5 μMm o n e n s i n ) .I n t r a -
cellular IL-13 and IFN-g accumulation by T cells was
detected by immunofluorescence-flow cytometry as pre-
viously described [12,17]. Proportions of cytokine produ-
cing cells were analyzed within T cells, gated based on a
standard viable forward and side scatter lymphocyte
gate and staining for CD3/CD5. Analysis of IL-4, IL-5,
and IL-10 was not included in the study because the
proportion of positive-expressing cells in freshly PBL
was too low (0.4%) to accurately assess in the majority
subjects, including asthmatics (not shown).
Analysis of proliferation and progenitor numbers
The number of divisions that IL-13
+ and IFN-g
+ T cell
progenitors undergo during culture was determined by
analysis of carboxyfluorescein diactetate succinimydl
ester (CFSE) dilution in CFSE-labeled PBL from female
control and female asthmatic subjects, as previously
described (12). Average division numbers and minimum
progenitor numbers were calculated for experiments of
CFSE-labeled PBL as described previously [12,15]. See
Additional File 1 for details of CFSE analyses.
Statistical analyses
Distributions of non-normalized data sets were signifi-
cantly non-Gaussian. Therefore, significance of differ-
ences in medians between non-normalized data sets was
tested with Mann-Whitney tests (two-tailed). Analyses
of accumulation of cytokine
+ T cell subsets in culture
were performed on data normalized as a percent of the
respective day 0 values (day 0 = 100%) because of the
variability in the absolute proportions of day 0 cytokine
+
T cells. Normalized data were log-transformed to obtain
approximate normality of distribution. Significance of
differences in transformed (geometric) means was tested
by Student’s t-tests (two-tailed, corrected for unequal
variances). Significance of gender and asthma status on
accumulation was tested by 2-way General Linear
Model analyses, with up to 2-way interaction model and
planned Tukey-Kramer multiple comparison tests. Sta-
tistical analyses were performed using GraphPad Prism
(4.0.3; San Diego California USA, http://www.graphpad.
com) and Number Cruncher Statistical Systems (NCSS,
2004; J. Hintze, Kaysville, Utah, http://www.NCSS.com)
software.
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Type 1 and type 2 T cell subsets in freshly isolated PBL
In freshly isolated human PBL, distinct subsets of T cells
are capable of producing IL-13 (IL-13
+) and IFN-g (IFN-
g
+). The median proportions of IL-13
+ and IFN-g
+
T cells did not differ significantly between non-asth-
matic (control) and atopic asthmatic (asthmatic) subjects
(IL-13
+: 0.8%, interquartile ranges (IQR): 0.5 - 2.1%, n =
21; and 0.9%, IQR: 0.5 - 2.5%, n = 25, respectively; p =
0.56); IFN-g
+:( 8 . 4 % ,I Q R :2 . 2-1 3 . 5 ,n = 20; and 5.4%,
IQR: 2.7 - 14.0, n = 25, respectively; p = 0.71).
Accumulation of type 1 and type 2 T cell subsets
CD3+CD28-mediated stimulation
To test whether T cell subsets in freshly isolated PBL
differ in their response to antigenic stimulation, PBL
were stimulated with CD3 and CD28 monoclonal anti-
body to mimic efficient antigenic stimulation by profes-
sional antigen-presenting cells (e.g., activated
macrophages, dendritic cells). The median proportion of
IL-13
+ T cells after 5-day culture with CD3+CD28-
mediated stimulation did not significantly differ between
control subjects and asthmatics (Table 1). In contrast,
the median proportion of IFN-g
+ T cells after 5-day
culture was significantly higher in asthmatics than in
control subjects.
After 5-day culture the total number of T cells from
both asthmatic and control subjects increased ~400%
above the day 0 number (Figure 1A). The number of IL-
13
+ T cells from both asthmatic and control subjects
likewise increased relative to the day 0 numbers,
although there was not a significant mean increase in
the proportion of IL-13
+ T cells from either group
(Figure 1B). There was a significant impact of gender on
the results (p = 0.0001), but no interaction between gen-
der and asthma observed (results of stratified analyses
are discussed below in “Gender effects on T cell subset
accumulation” section). The proportion of IFN-g
+
T cells decreased during culture for control subjects,
but increased for asthmatic subjects, such that changes
in proportion were different (p = 0.046) between groups
(Figure 1C). There was a significant mean increase in
number of IFN-g
+ T cells during culture for both asth-
matic and control subjects, and this increase was greater
for asthmatics compared to control subjects (p = 0.041).
Using starting (day 0) proportions of IL-13
+ and IFN-g
+
as covariates in Analyses of Covariance (ANCOVA) did
not change the significance of the above findings.
IL-4, IL-12 polarization effects
Under the ‘classical Th2-polarization’ culture condition
of CD3+CD28-mediated stimulation plus IL-2, IL-4,
and anti-IL-12, IL-13
+ T cells increased significantly in
number, with no significant difference between control
and asthmatic subjects (Figure 2A). Under the ‘classical
Th1-polarization’ culture condition of CD3+CD28-
mediated stimulation plus IL-2 and IL-12, IFN-g
+
T cells from control subjects increased in number with
a mean zero-change in proportion (Figure 2B), in con-
t r a s tt ot h a to b s e r v e di nt h eC D 3 - s t i m u l a t e dc o n d i t i o n
in the absence of IL-12 (Figure 1C). The mean change
in CD3+CD28+IL-12-stimulated accumulation of IFN-
g
+ T cells was similar for control and asthmatic sub-
jects. Because IFN-g
+ T cells from asthmatics accumu-
late to greater numbers in CD3+CD28-stimulated
cultures with IL-2 in the absence of IL-12, the
response of T cells specifically to IL-12 was assessed
by comparing IFN-g
+ Tc e l la c c u m u l a t i o ni nc u l t u r e s
with IL-2 + IL-12 relative to cultures with IL-2 + anti-
IL-12 (Figure 2C). Relative to the IL-2 + anti-IL-12
condition, IFN-g
+ T cell accumulation increased more
in cultures with IL-12, with this increase in both
number and proportion being significantly greater in
control subjects than in asthmatics.
IL-2 stimulated accumulation
IL-13
+ T cells also proliferate in response to IL-2, inde-
pendent of CD3/antigen-mediated stimulation, preferen-
tially accumulating in cultures relative to the major IL-
13
- T cell population (12, 15). Total T cell numbers did
not significantly change in PBL from both control and
asthmatic subjects in cultures with IL-2 (Figure 3A). In
PBL stimulated with IL-2, the median proportion of IL-
13
+ and IFN-g
+ T cells after 6-day culture was signifi-
cantly higher in asthmatics than in control subjects
(Table 1). IL-13
+ T cells from both asthmatic and con-
trol subjects significantly increased relative to starting
day 0 values, and this increase in accumulation was sig-
nificantly greater in asthmatic than in control subjects
Table 1 Proportions of IL-13
+ and IFN-g
+ T cells after
culture
Stimulus * Subset Subjects Median
† IQR
† np
‡
CD3+CD28 IL-13
+ Control 0.8% 0.6 - 4.3 17 0.67
+IL-2 Asthma 1.8% 0.5 - 4.2 18
IFN-g
+ Control 2.9% 0.6 - 7.8 11 0.035
Asthma 7.4% 5.1 - 20.2 19
IL-2 IL-13
+ Control 1.0% 0.7 - 3.2 24 0.0004
Asthma 4.5% 2.5 - 5.3 18
IFN-g
+ Control 4.1% 2.4 - 10.3 19 0.0076
Asthma 10.7% 7.2 - 24.2 19
* After 5-day (CD3+CD28+IL-2) or 6-day (IL-2) culture of PBL (anti-IL-12
monoclonal antibody included in all cultures), proportions of cytokine-
producing T cells were determined by flow cytometry.
† Median and 25%-75% interquartile range (IQR) of the proportion of IL-13+
or IFN-g
+ T cell subsets.
‡ p-value for the significance of difference between control and asthmatic
subjects (two-tailed Mann-Whitney test).
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interaction (p = 0.003) between gender and asthma sta-
tus for IL-2-stimulated increases in IL-13+ T cells, sug-
gesting gender-specific differences for the observed
associations with asthma (see “Gender effects on T cell
subset accumulation” section below for discussion of
stratified analyses). In control subjects, IFN-g
+ T cells
decreased in proportion (p =0 . 0 1 )a n dn u m b e r( p =
0.008) in cultures with IL-2 (Figure 3C). In stark con-
trast, IFN-g
+ T cells from asthmatic subjects increased
in both proportion (p = 0.007) and number (p =0 . 0 0 8 ) ,
and the differences in accumulation were significantly
different (p ≤ 0.0004) between the control and asthma
groups. For control subjects, IFN-g
+ cells increased in
proportion and number only when IL-12 was included
in the culture (not shown). A role for IL-12 or IL-23 in
t h ei n c r e a s ei nI F N - g
+ in PBL from asthmatics was
excluded because IL-12p40-neutralizing monoclonal
antibody were included in all cultures. Using starting
(day 0) proportions of IL-13
+ and IFN-g
+ as covariates
in ANCOVA did not change the significance of the
above findings.
Figure 1 CD3-stimulated accumulation of T cell subsets from control and asthmatic subjects. PBL from control (filled symbols) and atopic
asthmatic (open symbols) subjects were cultured 5-d with CD3+CD28 monoclonal antibody + IL-2 + anti-IL-12, and then stimulated and
analyzed for cytokine production by immunofluorescence-flow cytometry. Each symbol indicates the proportion (%) and number (n) of: (A) total;
(B) IL-13
+; and (C) IFN-g
+ T cells, expressed a percent of the respective day 0 values for each subject tested. Bars = geometric mean for each
parameter. p-values from two-tailed student t-tests for differences in geometric mean between control and asthmatic subjects are shown.
Figure 2 Effects of ‘classical’ polarization conditions on accumulation of T cell subsets. PBL from control and asthmatic subjects were
cultured 5-d with CD3+CD28 monoclonal antibody + IL-2 and IL-4 + anti-IL-12 (A), IL-12 (B, C), or anti-IL-12 (C), and then stimulated and
analyzed for cytokine production. Each symbol indicates the proportion (%) and number (n) of IL-13
+ (A) and IFN-g
+ (B) T cells, expressed as a
percent of respective the day 0 values for each subject tested. (C) Indicated are % and n of IFN-g
+ T cells in the IL-12 condition, expressed as a
percent of respective anti-IL-12 (control) condition values. Bars = geometric mean for each parameter. p-values from student t-tests for
differences in geometric mean between control and asthmatic subjects are shown.
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Race and gender may contribute to asthma risk, with
asthma being more common in African Americans than
in Caucasians (National Center for Health Statistics.
Asthma: http://www.cdc.gov/nchs/fastats/asthma.htm.
CDC. 2006), and, in adult asthmatics, more common in
pre-menopausal females than in males (reviewed by Bal-
zano et al. [18]). The asthma population used in this
study consisted of 60% Caucasian and 40% African-
Americans, and 55% females and 45% males. All data
were analyzed to consider the cofactors of race and gen-
der. There was no difference between Caucasian and
African American asthmatics in accumulation (IL-2-
and CD3- stimulated) of IL-13
+ or IFN-g
+ T cells, and
both Caucasian and African American asthmatic groups
showed greater accumulation of IL-2-stimulated accu-
mulation of IL-13
+ and IFN-g
+ T cells compared to
Caucasian controls (not shown). The number of African
American control subjects was not sufficient to enable
comparisons between racial groups in control subjects.
The data for IL-2-stimulated accumulation of IL-13
+
and IFN-g
+ T cell accumulation were stratified to
demonstrate the contributions of gender and asthma on
accumulation (Figure 4). There was a significant interac-
tion between asthma and gender for IL-2-stimulated
accumulation of IL-13
+ T cells (p = 0.003) but not IFN-
g
+ T cells (p = 0.42). Female asthmatics had significantly
greater IL-2-stimulated accumulation of IL-13
+ T cells
than both male and female controls (p < 0.001 for both)
and also male asthmatics (p < 0.01). For the 6 experi-
ments in which CD8 staining was available, IL-2-stimu-
lated accumulation of IL-13
+ T cells was greater in
female vs. males asthmatics for both CD8
- (mostly CD4
+)
and CD8
+ T cell subsets (Figure S1 in Additional File 1).
IFN-g
+ T cell accumulation was increased in both CD8
+
and CD8
- T cell subsets in asthmatics regardless of gen-
der (data not shown).
All but one of the female control subjects were atopic,
as determined by skin prick tests to a panel of common
aeroallergens. The differences between female asth-
matics and female controls remained significant (p <
0.001) when excluding the one nonatopic female control
subject (not shown). Skin prick tests were performed on
only 6 of the male control subjects, all of whom tested
positive. The mean increase in IL-13
+ T cells remained
similar for atopic nonasthmatic males compared to ato-
pic nonasthmatic females, as observed for the main ana-
lysis not restricted by atopy status (not shown). These
results demonstrate that the observed associations for
asthma- and gender-specific increases in IL-13
+ T cells
is a function of atopic asthma per se, rather than a func-
tion of atopy status alone.
The difference in IL-2-stimulated accumulation of IL-
13
+ and IFN-g
+ T cells between female and male asth-
matics remained significant when data from lung func-
tion studies (e.g., methacholine PC20, percent predicted
FEV1, % reversal in FEV1 by albuterol, percent predicted
forced vital capacity (FVC), FVC/FEV1) and other fac-
tors (age, serum IgE, body mass index) were considered
as covariates in GLM analyses (not shown). These cov-
ariates were not included in the final GLM models
because none of these variables significantly differed
between male and female asthmatics, nor correlated
with extent of T cell subset accumulation (see Table S1
Figure 3 IL-2-stimulated accumulation of T cell subsets. PBL from control (filled symbols) and atopic asthmatic (open symbols) subjects were
cultured 6-d with IL-2 + anti-IL-12, and then cells were stimulated and analyzed for cytokine production. Each symbol indicates the proportion
(%) and number (n) of: (A) total; (B) IL-13
+; and (c) IFN-g
+ T cells, expressed as a percent of the respective day 0 values, for each subject. Bars =
geometric mean for each parameter. p-values from two-tailed student t-tests for differences in geometric mean between control and asthmatic
subjects are shown.
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mulation of IL-13
+ T cells, there was a significant differ-
ence between male and female subjects overall
(p = 0.0001) and within asthmatic (p < 0.01) and control
(p < 0.03) populations, but not between asthma and
control populations within the same gender. An influ-
ence of gender on CD3+CD28-stimulated accumulation
of IFN-g
+ T cells was not detected.
Lack of influence of inhaled corticosteroids
Although inhaled corticosteroids for asthma control was
withheld for at least 12-h before blood draw, it is still
possible that this anti-inflammatory drug may impact
the peripheral blood T cells. To control for this poten-
tial confounder, two-way ANOVA were performed to
adjust for regular inhaled corticosteroid use and gender
for T cell subset accumulation in the asthma population
(Table 2). Regular steroid use did not impact IL-2-sti-
mulated accumulation of IL-13
+ and IFN-g
+ Tc e l l s .
Regular steroid use tended to decrease CD3+CD28-sti-
mulated accumulation of IL-13
+ and IFN-g
+ Tc e l l s ,
regardless of gender (no interaction effect). This obser-
vation actually strengthens the observed increased accu-
mulation of IFN-g
+ T cells in asthmatics compared to
controls, as regular steroid use would tend to lower the
mean accumulation of IFN-g
+ T cells in the asthma
population.
T oc o n f i r mt h a ta s t h m as t a t u s ,a n dn o td i f f e r e n c e si n
steroid use, determines the increased accumulation of
IL-13
+ and IFN-g
+ T cells, female asthmatics and con-
trols were compared, restricting the analysis to those
subjects that do not use inhaled steroids. The signifi-
cance levels for differences between female asthmatics
and controls for IL-2-stimulated accumulation of IL-13
+
Figure 4 Effects of gender and asthma on T cell subset accumulation. Data obtained in the experiments for Figures 2 and 4 were
reanalyzed, including both asthma and gender as independent variables in 2-way General Linear Model analyses of accumulation of IL-13
+ and
IFN-g
+ T cells. Each symbol indicates the number of: IL-13
+ (left panels) and IFN-g
+ (right panels) T cells, expressed as a percent of the respective
day 0 values for each subject after (A) 6-d culture with IL-2 + anti-IL-12 or (B) 5-d culture with CD3+CD28monoclonal antibody + IL-2 + anti-IL-
12. Bars = geometric mean for each parameter. p-values from planned Tukey-Kramer multiple comparison tests are shown.
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+ T cells and CD3+CD28-stimulated accumu-
lation of IL-13
+ and IFN-g
+ T cells were p = 0.0003,
0.08, 0.006, and 0.004 respectively (data not shown).
Overall these data suggest that regular steroid use before
the 12-h withdrawal of asthma-control medications do
not impact the significance of the findings in this study.
Mechanisms mediating differences in accumulation
Previous studies demonstrated that IL-2 stimulates accu-
mulation of IL-13
+ T cells by preferentially inducing
proliferation of IL-13
+ T cells [12,15]. A potential
mechanism to explain the greater accumulation of IL-13
+ in female asthmatics is a difference in IL-2-stimulated
proliferation. Representative plots of division numbers
(determined by CFSE fluorescence peaks) and the pro-
portion of IL-13
+ or IL-13
- T cells that had undergone
that number of divisions are shown in Figure 5A. In IL-
2-stimulated cultures, most IL-13
+ T cells from female
control and asthmatic subjects underwent approximately
4-5 divisions in 6 days, whereas few IL-13
- T cells
divided at all. There was no significant difference
between female control and asthmatic subjects for the
average number of divisions by IL-13
+ T cells (Figure
5B). In CD3+CD28-stimulated cultures, IL-13
+ and IL-
13
- T cells proliferated to a similar extent, undergoing
~4-6 divisions in 5 days, with no significant differences
between control and asthmatic subjects (not shown).
The theoretical maximum increase in IL-13
+ T cells
expected during culture, on the assumption that no IL-13
+
T cells are lost (via apoptosis or differentiation), can be
calculated as 2
average division number. The actual increase in
the number of IL-13
+ T cells from control subjects was
87 ± 14% lower (n = 6) than the theoretical maximum
increase; the actual increase in IL-13
+ Tc e l l sf r o ma s t h -
matics was 43 ± 35% lower (n = 6) than the theoretical
maximum, significantly lower than that for control sub-
jects (p = 0.03). These data indicate that during culture
there are losses of the progenitors of IL-13
+ T cells, and
that this loss of progenitors is greater in female control
subjects than in female asthmatics (Figure 5B). Indeed, in
cultures derived from female asthmatics, few IL-13
+ Tc e l l
progenitors are lost–approximately one-quarter the loss of
progenitors that occurs for control subjects. There were
no significant differences between male asthmatics and
male controls (and male and female controls overall) for
any of these CFSE-derived parameters (not shown). There-
fore, reduced loss of IL-13
+ T cells rather than increased
proliferation is responsible for increased accumulation of
IL-13
+ T cells in PBL from female asthmatics.
IFN-g
+ T cells from asthmatics did not proliferate more
than those from control subjects (Figure 5B). The major-
ity (~80%) of IFN-g
+ T cell progenitors from control sub-
jects were lost during culture of PBL from control
subjects. As with IL-13
+ T cells, the loss of IFN-g
+ Tc e l l
Table 2 Impact of regular inhaled corticosteroid use on T cell subset accumulation
Culture stimulus T cell subset Asthma group Accumulation, % of day 0 numbers * p-value
†
Gender Steroid
￿ Geo. Mean Geo. Mean ± S.D. n Gender Steroid Interaction
IL-2 IL-13
+ Female No 622 326 - 1184 6 0.0016 0.16 0.22
Yes 662 342 - 1280 5
Male No 116 73 - 184 2
Yes 285 155 - 525 5
IFN-g
+ Female No 677 229 - 1994 6 0.41 0.28 0.40
Yes 170 69 - 420 4
Male No 206 101 - 423 3
Yes 173 21 - 1415 6
CD3+CD28 IL-13
+ Female No 5427 1281-22,996 3 0.0016 0.044 0.33
+ IL-2 Yes 1352 571 - 3,201 6
Male No 656 393 - 1,094 3
Yes 388 204 - 738 6
IFN-g
+ Female No 3730 886 - 15,702 3 0.073 0.023 0.98
Yes 691 241 - 1,982 6
Male No 1035 396 - 2,707 3
Yes 186 36 - 962 7
* Two-way General Linear Model analysis was performed to adjust for the impact of regular steroid use and gender on accumulation of T cell subsets from
asthmatic subjects. Geo. Mean = geometric mean for the numbers of IL-13+ or IFN-g+ T cells relative to the respective day 0 numbers after culture with the
indicated culture stimulus. S.D. = standard deviation.
† The significance of differences in geometric mean between males and females (gender) and between asthma subjects that use or don’t regularly use inhaled
steroids (steroid), and the significance of interaction between gender and steroid effects.
￿ Indicates whether asthma subjects regularly use inhaled corticosteroids for asthma control. Note that all asthma subjects refrained from using asthma control
medications 12-h before blood draw. No subjects regularly used oral corticosteroids for asthma control.
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Therefore, the increased accumulation of the IFN-g
+
T cell subset from asthmatics, relative to control subjects,
is a function of increased maintenance of T cell subset
progenitors rather than enhanced proliferation.
Discussion
Our study provides the first evidence to date that T cells
from atopic asthmatic and nonasthmatic control subjects
differ in their accumulation of T cell subsets in response
to CD3+CD28-mediated and antigen-independent stimu-
lation. Moreover, gender plays a significant role in deter-
mining these responses in type 2 T cell accumulation.
IL-2 stimulated increases in IL-13
+ T cells were signif-
icantly higher in PBL from asthmatics than in PBL from
control subjects, and this increase is almost totally attri-
butable to the female population of asthmatics studied.
That the increased accumulation of IL-13
+ Tc e l l sw a s
observed in female but not male asthmatics, and the
association was maintained when analysis was restricted
to only atopic subjects, indicates that the effect was a
function of asthma and not atopy per se. Whether there
is also an effect of atopy per se on accumulation of
IL-13+ T cells should be tested next, by comparing non-
atopic nonasthmatic and atopic nonasthmatic healthy
control subjects. CD3+CD28-stimulated accumulation of
Figure 5 Proliferation of IL-13
+ T cells from control and asthmatic subjects. CFSE-labeled PBL from female control (n =6 )a n df e m a l e
atopic asthmatic subjects (n = 7) were cultured 6-d with IL-2 and anti-IL-12 or 5-d with CD3+CD28 monoclonal antibody + IL-2 + anti-IL-12, and
then stimulated and analyzed for cytokine production. (A) Proportions (mean ± S.D.) of cells in IL-13
+ and IL-13
- T cell populations (y-axis) that
had undergone the indicated number of divisions (x-axis). (B) Compiled analysis for: cell numbers of the indicated T cell population, expressed as
a percent of day 0 values, geometric mean + 95% CI (left panel); the average number of divisions the indicated T cell population underwent
during culture, mean ± SD (middle panel); the percentage loss of progenitors of the indicated T cell population, mean ± SD (right panel). * p <
0.05 for difference in (geometric) mean.
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+ T cells was also greater in female subjects, but
was not influenced by asthma status. IFN-g
+ T cell accu-
mulation, when stimulated by either CD3+CD28 or IL-2,
was significantly greater in cells from asthmatics relative
to controls, with no effect of gender. Interestingly, in
“Th1-polarizing” conditions including IL-12, IFN-g+
T cells increased to similar extents in both asthma and
control groups. We would hypothesize that the impact
of IL-12 is partially redundant. In cultures with IL-12,
existing IFN+ cells survive to a greater extent than
in the absence of IL-12 for controls, but in asthmatics
survival is already near its maximal limit so as to not be
further increased by IL-12.
Unlike the majority of T cells (IL-13
- and IFN-g
+ sub-
sets), IL-13
+ T cells increase in number and proportion
when stimulated with IL-2, even in the absence of anti-
genic stimulation. This accumulation occurs via selective
proliferation of the IL-13
+ T cell subset [12,15]. In
female asthmatic subjects, IL-13
+ T cells accumulate to
even greater numbers, with about a 4-fold greater
increase than that observed in female control and male
asthmatic subjects. CFSE analyses demonstrate the
mechanism is not by a further increase in IL-2-stimu-
lated proliferation, but rather via a reduction in the loss
of IL-13
+ T cells during culture.
Our data demonstrating enhanced accumulation of
not only IL-13
+ but also IFN-g
+ T cells from asthmatic
subjects in response to IL-2 suggest the importance of
antigen-independent stimulation of T cells in asthma.
Cytokine-stimulated (bystander) accumulation of T cells
may potentially explain allergen-independent sensitiza-
tion in asthmatics, e.g., respiratory infection leading to
an IL-2- or IL-15-induced proliferation of resident
memory, viral antigen-non-specific, allergen-specific
type 2 T cells, conditions which have been speculated to
be relevant to the development of asthma [19]. Viral
infections have been implicated in asthma pathogenesis
and exacerbations by numerous epidemiologic studies,
although limited mechanistic insight exists [1,3,4,7,8].
Pathogens (bacteria, virus) induce cytokine production
by monocytes, macrophages, and dendritic cells (i.e.,
monocytic cells). Tissue damage (e.g., products of necro-
tic cells; endothelins released by endothelia or epithelia,
platelet-derived factors), independent of pathogen infec-
tion, can also induce cytokine production by monocytic
cells [20,21]. IL-15, a cytokine produced by monocytic
cells, is capable of inducing antigen-independent,
bystander proliferation of IL-13
+ T cells (unpublished
observations). These bystander events need not necessa-
rily take place in the airways. They may also occur in
the lymph nodes that drain the lungs where both pre-
viously activated memory cells and naïve, type 2 T cells
could either be increased in number prior to being sti-
mulated by allergen or trafficking to the lungs. Thus,
although starting numbers of IL-13
+ T cells did not sig-
nificantly differ between asthmatics and non-asthmatics,
enhanced bystander accumulation of type 2 T cells may
nevertheless lead to an acute increase in numbers of
IL-13
+ T cells in asthmatics during allergen- or patho-
gen- induced immune responses.
Increased accumulation of both IL-13
+ and IFN-g
+ in
asthmatics contradicts the Th2 hypothesis of asthma, yet
is consistent with observations of IFN-g being elevated
(with type 2 cytokines) in some asthmatics [4,5]. It has
been suggested that microbial infections can contribute to
the development of allergic asthma, as well as to exacerba-
tions in subjects with established asthma [1,3,4,7,8]. In
asthmatic compared to nonasthmatic subjects, microbe-
specific IFN-g
+ T cells can increase to greater numbers
during infection. Additionally, non-microbe specific IFN-
g
+ T cells could also increase in asthmatics, potentially
increasing any allergen-specific IFN-g
+ T cells as well. An
acute increase in IFN-g production during an allergic reac-
tion, or reaction to microbial infection, could exacerbate
inflammation in asthmatics by increasing the recruitment
and activation of immune cells [6].
The mechanism contributing to gender differences in
IL-13
+ T cell accumulation is unclear. Between post-pub-
erty and pre-menopause years, females have a higher inci-
dence of developing asthma than males (reviewed by
Balzano et al. [18]). However, during pre-puberty, asthma
development tends to occur somewhat more frequently in
boys. A portion of adult, asthmatic women also experience
perimenstrual worsening of asthma symptoms [22]. These
observations suggest the involvement of female sex hor-
mones in the increased accumulation of IL-13
+ T cells.
Potential explanations for enhanced IL-13
+ T cell accumu-
lation selectively in female asthmatics is an interaction
between high levels of female sex hormones and the
asthma/atopic environment or asthma/atopy susceptibility
genetic polymorphisms. The effects of gender and asthma
on IL-13
+ T cells could be either from epigenetic, develop-
mental imprinting from continuous hormone exposure,
or, alternatively, from acute stimulation by hormones
before blood draw. Interestingly, increased accumulation
of IL-13
+ T cells under CD3+CD28-stimulatory conditions
was also observed in females, but was in this case indepen-
dent of asthma status. It is tempting to speculate if hormo-
nal-driven epigenetic changes to IL-13
+ T cells in females
may have broader consequences for susceptibility to type
2 T cell-associated autoimmune diseases that predomi-
nantly occur in females, e.g., lupus and multiple sclerosis.
Decreased numbers of regulatory T cells have been
hypothesized to contribute to the development of
asthma [11]. Corticosteroid use is suggested to decrease
the development of adaptive IL-10-producing TR1 regu-
latory T cells [11]. Perhaps female sex hormones may
also contribute to decrease TR1 development and
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+ T cells in
female asthmatics. The main mechanism described for
inhibition of T cell accumulation by regulatory T cells is
inhibition of proliferation. Increased accumulation of IL-
13
+ and IFN-g
+ T cells in asthmatics resulted from
decreased loss of cytokine
+ cells rather than increased
proliferation relative to controls. Also, increased accu-
mulation of IL-13
+ T cells in female asthmatics was
observed only for the IL-2-stimulated condition and not
the CD3+CD28-mediated condition. For these reasons it
seems less likely that differences in regulatory T cells
account for the observed increased accumulation of
T cell subsets in asthmatics.
Conclusions
In conclusion, our data demonstrate that both type 1
and type 2 T cell subsets increase to a greater extent in
asthmatic than control subjects in response to antigen-
independent, cytokine-mediated stimulation, with the
increased accumulation of type 2 T cells exclusively in
female asthmatics. These results provide explanations
for the higher frequency of adult asthma in females and
for the apparently paradoxical increase of both IFN-g
and IL-13 in the lungs of a subset of allergen-challenged
asthmatics.
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